Advanced search
Instruments
| Name | Stock exchange | Average volume | Price | Type | ||
|---|---|---|---|---|---|---|
| CHA VACCINE RESEARCH INSTITUTE | A261780 | Korea S.E. | 61,399 |
4,645
KRW
 | Stock | |
| HANG LUNG GROUP LIMITED | 10 | Hong Kong S.E. +4 Other | 2,321,701 |
8.68
HKD
| Stock | |
| HANG LUNG GROUP LIMITED | HLU | Deutsche Boerse AG | - |
1.01
EUR
| ||
| HANG LUNG GROUP LIMITED | HLU | Börse Stuttgart | - |
1
EUR
| ||
| HANG LUNG GROUP LIMITED | HNLGF | OTC Markets | 0 |
1.18
USD
| ||
| HANG LUNG GROUP LIMITED | HLU | Berne S.E. | - | - CHF
| ||
| HANG LUNG PROPERTIES LIMITED | 101 | Hong Kong S.E. +5 Other | 36,551,535 |
7.13
HKD
| Stock | |
| HANG LUNG PROPERTIES LIMITED | AOP | Deutsche Boerse AG | - |
0.835
EUR
| ||
| HANG LUNG PROPERTIES LIMITED | AOP | Börse Stuttgart | - |
0.81
EUR
| ||
| HANG LUNG PROPERTIES LIMITED | AOP | BOERSE MUENCHEN | 217 |
0.87
EUR
| ||
| HANG LUNG PROPERTIES LIMITED | HLPPF | OTC Markets | 55,521 |
0.9321
USD
| ||
| HANG LUNG PROPERTIES LIMITED | AOP | Berne S.E. | - | - CHF
| ||
| LUNG KEE (BERMUDA) HOLDINGS LIMITED | 255 | Hong Kong S.E. | - |
1.34
HKD
| Stock | |
| MAY & BAKER NIGERIA PLC | MAYBAKER | Nigerian S.E. | 228,891 |
6.7
NGN
| Stock | |
| KWONG LUNG ENTERPRISE CO., LTD. | 8916 | Taipei Exchange | 194,045 |
60.4
TWD
| Stock | |
| LUNG HWA ELECTRONICS CO., LTD. | 2424 | Taiwan S.E. | 37,520 |
30.35
TWD
| Stock | |
| SILVER VERDE MAY MINING CO., INC. | SIVE | OTC Markets | 0 |
0.000001
USD
| Stock | |
| LUNG PIEN VACUUM INDUSTRY CO., LTD. | 5267 | Taipei Exchange | 6,609 |
37.6
TWD
| Stock | |
| LUNG MING GREEN ENERGY TECHNOLOGY ENGINEERING CO., LTD. | 3018 | Taiwan S.E. | 36,993 |
15.6
TWD
| Stock |
News (280)
Companies (980)
Nike, Inc. specializes in the design, manufacturing and marketing of sports shoes, clothing, and equipment. The group's products are sold primarily under the names Nike, Jordan, Converse Chuck Taylor, All Star, One Star, Star Chevron and Jack Purcell. Net ...
Asahi Group Holdings, Ltd. specializes in the production and marketing of beer and non alcoholic beverages. Net sales break down by family of products as follows: - alcoholic beverages (31%): beer, liqueurs, wine and whisky (brands Asahi Super Dry, Asahi ...
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (neb ...
Ares Capital Corporation is a specialty finance company focused on providing direct loans and other investments in private middle market companies in the United States. The Company invests primarily in first lien senior secured loans (including unitranche ...
Airports of Thailand Public Company Limited is a Thailand-based company that is engaged in airport operations and other business related to or affiliated with the airport business. The Company is engaged in airport management business, hotel business, gro ...
Dubai Electricity and Water Authority PJSC is a United Arab Emirates-based utility services provider. The Company distributes electricity and water and serves residential and commercial customers in the United Arab Emirates. The principal activities of th ...
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination ant ...
PT Champ Resto Indonesia, Tbk is an Indonesia-based company that operates restaurants. It owns brands, such as Raa Cha, Gokana, BMK, Platinum, Chopstix and Monsieur Spoon. Raa Cha presents a way of dining, equipped with personal and cooking utensils. Goka ...
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...
Puer Lancang Ancient Tea Co Ltd is a China-based company principally engaged in the manufacture of tea products. The Company is a primarily engaged in the production of tea products, food production and sales. The Company's main brand is Lancang Ancient T ...
Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. The Companyâs technologies are designed to administer disease-fighting genes to provide new therapies for large patient populat ...
bioAffinity Technologies, Inc. is a biotechnology company focused on commercializing noninvasive tests for the detection of early-stage cancer and lung disease. The Company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of ...
CHA Vaccine Research Institute Co Ltd is a Korea-based company principally engaged in the vaccines and immunotherapy research business based on based on adjuvant platform technology. The Company is engaged in the research and development (R&D) of premium ...
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bi ...
Innovent Biologics Inc is an investment holding company principally engaged in biopharmaceuticals. The Company and its subsidiaries are engaged in research and development of antibody and protein medicine products, sale and distribution of pharmaceutical ...
Neola Medical AB, formerly GPX Medical AB is a Sweden-based company that is involved in development of medical instruments. The Company's business concept is to commercialize the Company's medical technology product for continuous lung monitoring based on ...
Biodesix, Inc. (Biodesix) is a diagnostic solutions and services company. The Company develops diagnostic tests addressing clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers over five Medicare-covered ...
Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solut ...
ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company's technology comprises an antibody t ...
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for t ...
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions i ...
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritin ...
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations ...
Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resista ...
ROUND ONE Corporation is a Japan-based company principally mainly engaged in the comprehensive amusement business. The Company operates in two geographic segments: Japan and the United States. The Company is engaged in the operation of indoor leisure comp ...
Peak Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on commercializing therapeutics that aim to improve and address unmet medical needs for patients with inflammatory, rare and specialty diseases and cancer. The Companyâ ...
Tiansheng Pharmaceutical Group Co LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company's main products include pediatric lung cough particles, erythromycin enteric-coated c ...
4DMedical Limited is an Australia-based medical technology company. Through its flagship patented XV Technology, the Company enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sens ...
SAN FU CHEMICAL Co., Ltd. is a Taiwan-based company primarily engaged in the production and sales of fine chemicals and basic chemicals. Its fine chemicals include developers, etchants, stripping liquid, dilution and washing liquid products. Its basic che ...
Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable pl ...
Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable pl ...
LungLife AI, Inc. is a developer of clinical diagnostic solutions for lung cancer. The Company is engaged in the development and commercialization of its lung cancer early detection test. Using a minimally invasive blood draw, its LungLB test is designed ...
Kyoto Financial Group Inc is a Japan-based company mainly engage in the management and administration of banks and other companies that may be made subsidiaries under the Banking Law, as well as other businesses incidental and related thereto. The Kyoto B ...
Lyft, Inc. is a multimodal transportation network in the United States and Canada that offer access to a variety of transportation options through its platform and mobile-based applications. The Lyft Platform provides a marketplace where drivers can be ma ...
Australian Foundation Investment Company Limited is an investment company, which is focused on investing in Australian and New Zealand equities. Its investment objective is to provide shareholders with investment returns through access to a stream of fran ...
AGNC Investment Corp. is an internally managed real estate investment trust (REIT). The Company provides private capital to the United States housing market, enhancing liquidity in the residential real estate mortgage markets and, in turn, facilitating ho ...
Restoque Comercio e Confeccoes de Roupas SA, formerly Le Lis Blanc Deux Comercio e Confeccoes de Roupas SA, is a Brazil-based company primarily engaged in the fashion industry. The Company focuses on the design, development, manufacture and trade of appar ...
Kuber Resources Corp is engaged in trading, distribution, and consultancy company. The Company focuses on tea planting and sales, research, and development. The Companyâs business scope includes partnering with tea plantations for tea production, such a ...
La Française des Jeux (FDJ) is the leading gambling operator in France. The activity is organized around 2 categories of games: - lottery games: draw games (Lotto®, Euromillions, Bingo Live, KENO Gagnant à Vie, etc.) and instant games (Millionaire, Cash, ...
PIMCO Dynamic Income Fund (the Fund) is a diversified closed-end management investment company. The Funds primary investment objective is to seek current income and secondary objective is capital appreciation. The Fund normally invests worldwide in a port ...
FS KKR Capital Corp. is an externally managed, non-diversified, closed-end management investment company, which regulates as a business development company (BDC). It is focused on providing customized credit solutions to private middle market United State ...
Terreno Realty Corporation acquires, owns, and operates industrial real estate in six coastal markets in the United States, such as Los Angeles; Northern New Jersey/New York City; San Francisco Bay Area; Seattle; Miami, and Washington, District of Columbi ...
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. The Companyâs LungFit platfo ...
Antengene Corporation Limited is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. The Company is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. T ...
Gunsynd plc is a United Kingdom-based investing company. The Company's investing policy is to invest in and/or acquire companies and/or projects within the natural resources sector, life sciences sector (concentrating on but not being limited to, plant-ba ...
JLogo Holdings Limited is a Singapore-based investment holding company, which owns and operates restaurants in Singapore under different brands and owns artisanal bakery chains in Malaysia. Its segments are dining operations and artisanal bakery. The dini ...
Nuveen Multi-Asset Income Fund (the Fund) is a diversified closed-end management investment company. The Fundâs investment objective is to provide a total return through high current income and capital appreciation. Under normal circumstances, the Fund ...
BibbInstruments AB is a Sweden-based medical technology company. It develops and sales biopsy instruments, which are based on technology platform EndoDrill. The drill function enables early cancer diagnosis, especially in deep skin tissues. The portfolio ...
Grande Asset Hotels and Property Public Company Limited is a Thailand-based company. The Company is engaged in hotel, property development and rental businesses. The Company is focused on the investment in internationally and globally managed brand of fou ...
John Hancock Investors Trust (the Fund) is a closed-end management investment company. The Fund's primary investment objective is to generate income for distribution to its shareholders, with capital appreciation as a secondary objective. The Fund also ma ...
Amoy Diagnostics Co Ltd is a pharmaceutical company engaged in research, development, production and sales of molecular diagnostic products. The Company provides testing reagents and testing services for tumor diagnosis. The Companyâs testing reagent pr ...
Galera Therapeutics, Inc. is a biopharmaceutical company focused on developing a pipeline of novel, therapeutic candidates that have the potential to transform radiotherapy in cancer. The Companyâs lead product candidate, avasopasem manganese (avasopase ...
Gyre Therapeutics, Inc. is a biotechnology company. The Company is engaged in the research, development, manufacturing and commercialization of drugs for organ fibrosis. It is primarily focused on the development and commercialization of Hydronidone (F351 ...
Y Biologics Inc is a Korea-based company principally engaged in the new drug development business. The Company is principally engaged in the research and development of new cancer antibody drugs for small cell lung cancer, liver cancer, solid cancer as we ...
ST Group Food Industries Holdings Limited is an Australia-based investment holding company. The Companyâs food and beverage retails segment includes operations with respect to all franchise and its owned restaurants and stores. The supply chain segment ...
abrdn Global Premier Properties Fund (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to seek high current income and capital appreciation. The Fund may invest up to 35% of its managed assets in sec ...
Qiansui International Group Co Ltd, formerly Ariel Clean Energy Inc, is a shell company. The Company is engaged in seeking new business opportunities with business entities for merger with or acquisition of a target business. The Company may seek a busine ...
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidat ...
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonarya ...
Prime Medicine, Inc. is a biotechnology company engaged in creating and delivering the gene editing therapies to patients. It deploys its Prime Editing platform, a gene editing technology, to develop a new class of differentiated, one-time genetic therapi ...
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Its initial candidate is epetraborole, which is a potential onc ...
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development ...
Cadence Opportunities Fund Limited is an Australia-based company, which is engaged in investing primarily in securities listed both in Australia and internationally. The Company may take short positions and may also deal in derivatives for hedging purpose ...
Inhibitor Therapeutics, Inc. is a pharmaceutical development company. The Company is focused on developing and commercializing therapeutics based on already approved active pharmaceuticals that have patent-protected methods of use and/or methods of delive ...
Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, its dry powde ...
EV Minerals Corporation is a Canadian exploration company focused on mineral exploration and development. The Company focuses on the EV Nickel Project, the host of the nickel-copper-cobalt deposit. The Project comprises approximately 32 mineral claims cov ...
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of novel inhaled therapeutic products intended to prevent and treat respiratory and other diseases with important unmet medical needs using its patent ...
Asia Hotel Public Company Limited is a Thailand-based company. The Companyâs segments include room service, food and beverage and rental of shopping complex, and real estate. The Company and its subsidiaries, Asia Pattaya Hotel Co., Ltd. and Asia Airpor ...
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development, and commercialization of medicines. Its product, YUPELRI (revefenacin) inhalation solution is indicated for the maintenance treatment of patients with chronic ...
Savara Inc. is a clinical-stage biopharmaceutical company, which is focused on rare respiratory diseases. The Companyâs lead program, molgramostim nebulizer solution (molgramostim), is an inhaled biologic, specifically an inhaled granulocyte-macrophage ...
Aceragen Inc is a clinical-stage biopharmaceutical company. The Company is focused on the clinical development, and commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious un ...
Lung Kee Bermuda Holdings Ltd is an investment holding company principally engaged in the mould base business. The Company is engaged in the manufacture and sale of mould bases and related products. The Company sells its products in China, America, Europe ...
Jumbo Group Limited is a Singapore-based investment holding company. It is a multi-dining concept food and beverages (F&B) company. It is engaged in the operation and management of restaurants and manufacturers of food stuff. The Company operates in Singa ...
Eaton Vance Municipal Bond Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income tax. The Fund invests primarily in debt securities issued by municipali ...
Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is l ...
Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a portfolio of novel and molecular glue degraders (MGDs) for patients living with serious diseases in the areas of oncology and autoimmune, and m ...
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain ...
NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commerci ...
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing servi ...
BioAdaptives, Inc. manufactures and distributes natural plant and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; resistance to stress ...
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodu ...
Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targetin ...
DoubleLine Income Solutions Fund (the Fund) is a diversified, closed-end management investment company. The Fundâs primary investment objective is to seek high current income and its secondary objective is to seek capital appreciation. The Fund seeks to ...
TransJamaican Highway Limited is a Jamaica-based company. The Company's core business activity is the development, operation and maintenance of a tolled road network known as the TransJam Highways, which is a 49.9 kilometer (km) tolled motorway with two d ...
Charn Issara Development Public Company Limited is a Thailand-based company engaged in the sales or lease of office condominiums and real estate development. The Company operates through four segments: real estate development, lease of office condominiums ...
Nuveen Select Tax-Free Income Portfolio (the Fund) is a diversified closed-end management investment company. The Fundâs investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. T ...
Australasian Metals Limited is an Australia-based exploration company. The Company is focused on lithium, gold and bauxite/titanium projects in the Northern Territory and Queensland. The Company's projects include May Queen Gold Project, May Queen South B ...
Qian Yuan Baixing, Inc., through Panjin Chunqiu Century Industrial Co., Ltd. (Chunqiu), is focused on selling goods and services on the Internet. The Company also, through Hangzhou Mai Jin Li Biotechnology Co., Ltd (Mai Jin Li), is an enterprise specializ ...
Bridge Biotherapeutics, Inc. is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The products mainly consist of ulcerative colitis medicine BBT-401, autoxin inhibitor BBT-877, non-small cell lung cancer m ...
Aptamer Sciences Inc is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The Company provides services include aptamer synthesis and aptamer discovery. The Company also develops biopharmaceuticals such as ...
Invesco Bond Fund (the Fund) is a diversified, closed-end management investment company. The investment objective of the Fund is to seek interest income while conserving capital. The Fund invests primarily in fixed-rate United States investment grade corp ...
Great Tang Bid Technology, Inc., formerly ESP Resources, Inc., is a shell company and has no operations. The Company intends to merge or acquire an operating business to commence operations and generate revenue. The Company businesses may include developm ...
Kai BioTech Co Ltd is a Korea-based company mainly engaged in the medical business based on radioactive fusion technology. The Company is engaged in the manufacture and sale of radiopharmaceuticals used in the diagnosis of oncology, prostate, liver, lung ...
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse even ...
AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company is engaged in the development of therapeutic products from its i-body platform. The Company has five active development programs ranging from discovery to Phase II cli ...
Eaton Vance New York Municipal Bond Fund is a non-diversified, closed-end management investment company. The Fundâs investment objective is to provide current income exempt from federal income tax. During normal market conditions, at least 80% of the Fu ...
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as t ...
Tellgen Corp is a company engaged in research, development, production and sales of in vitro diagnostic reagents and instruments. The Company's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic p ...
Betta Pharmaceuticals Co Ltd is a company mainly engaged in research, development, production and sales of innovative drugs for the treatment of malignant tumors. The Company's primary product is its self-developed icotinib hydrochloride (Conmana), a smal ...
MFS Intermediate Income Trust (the Fund) is a diversified closed-end management investment company. The Fundâs investment objective is to seek high current income but may also consider capital appreciation. The Fundâs investment adviser, Massachusetts ...
Insiders
Currently, May Lung Cha holds the position of Non-Executive Chairman of Hong Kong Exchanges & Clearing Ltd. and Chairman of Hong Kong Stock Exchange (a subsidiary of Hong Kong Exchanges & Clearing Ltd.) and Non-Executive Chairman at The HongKong & Shanghai Banking Corp. Ltd. She is also Member-Executive Council at Government of Hong Kong Special Administrative Region, Member of The State Bar of California and Member of Millstein Center for Corporate Governance & Performance and on the board of 6 other companies. In her past career Ms. Cha held the position of Chairman of Financial Services Development Council. She received an undergraduate degree from the University of Wisconsin and a graduate degree from Santa Clara University.
Suk-Yong Cha is a businessperson who has been at the head of 9 different companies and occupies the position of Chief Executive Officer of Clean Soul Ltd. and Vice Chairman & Chief Executive Officer for LG Household & Health Care Ltd., Chief Executive Officer for TFS Singapore Pte Ltd. (a subsidiary of LG Household & Health Care Ltd.). He previously held the position of President, Chief Executive Officer & Director at Ssang Yong Paper Co., Ltd., Chief Executive Officer for Coca-Cola Korea Bottling Co. Ltd., Chief Executive Officer of The Face Shop Korea Co., Ltd., Chief Executive Officer of Everlife Co., Ltd., Chief Executive Officer for Ginza Stefany Cosmetics Co. Ltd. and President, Chief Executive Officer & Director at Haitai Confectionery & Foods Co., Ltd. Suk-Yong Cha received an MBA from Cornell University.
Albert Cha occupies the position of Managing Partner at Frazier Management LLC. He is also on the board of 6 other companies. He previously held the position of Consultant at Oracle Corp. and Managing Partner at Vivo Capital LLC. He received a graduate degree and an undergraduate degree from Stanford University, a doctorate from David Geffen School of Medicine and a doctorate from the University of California, Los Angeles.
Presently, Dong-Seok Cha occupies the position of Auditor for Konjiam Yewon Co., Ltd. He is also Chief Financial Officer & Director at LG Chem Ltd. In his past career he held the position of Managing Director-Finance at LG Corp.
Ms. Won Lung is a Chief Compliance Officer at Intercorp Financial Services, Inc. and a Chief Compliance Officer at Banco Internacional del Perú SAA Interbank. Ms. Lung was previously employed as a Principal-General Security by BNP Paribas Investment Services LLC and a Vice President & Project Manager by Suntrust Bank /Fl/. She received her undergraduate degree from Florida International University and an MBA from Nova Southeastern University, Inc..
Ke Bing Cha is currently the Chairman-Supervisory Board at Jiangxi Copper Co., Ltd.
Presently, Manfred May holds the position of Chairman-Supervisory Board for CytoTools AG and Chief Executive Officer & Managing Director at Dr. May Pharma Consult GmbH. He previously occupied the position of Managing Director at Merck KGaA.
Douglas J. May is SVP, General Counsel, Compliance & Ethics Officer at Magellan Midstream Partners LP and SVP, General Counsel, Compliance & Ethics Officer at Magellan GP LLC (a subsidiary of Magellan Midstream Partners LP). Mr. May previously held the position of Associate Attorney at Skadden, Arps, Slate, Meagher & Flom LLP.
May Shana'a occupies the position of Senior Vice President-Research & Development at Beiersdorf AG. She is also Vice President-Technology & Growth Strategy at Ashland LLC.
Peter William May is a businessperson who founded Trian Fund Management LP and who has been at the head of 8 different companies. He is President & Founding Partner at this company. Mr. May is also Co-Chairman at New York Philharmonic, Chairman at Leni & Peter May Family Foundation, Partner at The Partnership for New York City and Founding Member at The Laura Rosenberg Foundation, Inc. and on the board of 7 other companies. In the past he held the position of Chairman at The Mount Sinai Hospital, President & Chief Operating Officer at Trian Group LP, President & Chief Operating Officer for Triangle Industries, Inc., Trustee at The Carnegie Hall Society, Inc., President & Chief Operating Officer of Triarc Cos., Inc., Chairman for UJA-Federation of New York and Trustee at 92nd Street Young Men's & Young Women's Hebrew Association. Peter William May received an undergraduate degree from The University of Chicago and an MBA from The University of Chicago Booth School of Business.
Ms. May Yap is a Chief Information Officer & Senior Vice President at Jabil, Inc.
Mr. Thomas J. May, CPA, is a Chairman at Eversource Energy Foundation, Inc., a Chairman at NSTAR Gas Co., an Independent Director at Bank of America Corp. and a Chairman at Stonehill College, Inc. He is on the Board of Directors at Bank of America Corp., Nstar Foundation, Edison Electric Institute, John F. Kennedy Library Foundation, Liberty Mutual Group, Inc., Liberty Mutual Holding Co., Inc., Liberty Mutual Insurance Co., The Boston Chamber of Commerce and Dana-Farber Cancer Institute, Inc. Mr. May was previously employed as a Non-Executive Chairman by Viacom, Inc., a Chairman, President & Chief Executive Officer by Eversource Energy, a Chairman, President & Chief Executive Officer by Eversource Energy Service Co., a Chairman by Yankee Gas Services Co., a Chief Financial Officer & Senior Executive VP by Canadian Imperial Bank of Commerce, a President, Chief Executive Officer & Director by Nstar Electric & Gas Corp., a Chairman, President & Chief Executive Officer by Boston Edison Co., a Chairman by Hydro One Ltd., a Chief Executive Officer & Trustee by NSTAR, a Trustee by NSTAR Electric Co., a Chairman by The Connecticut Light & Power Co., and a Chairman by The Massachusetts Business Roundtable. He also served on the board at Jarislowsky, Fraser Ltd., DBRS Ltd., DBRS, Inc., Public Service Company of New Hampshire, TMX Group, Inc., Western Massachusetts Electric Co., Deluxe Business Operations, Inc., FleetBoston Financial Corp., Greater Boston Chamber of Commerce and Jobs for Massachusetts, Inc. He received his undergraduate degree from Stonehill College, Inc. and a graduate degree from Bentley University.
Presently, John C. May is Chairman, President, CEO & COO at Deere & Co. In his past career Mr. May held the position of Managing Director at John Deere (Tianjin) Co. Ltd., Vice President-Global Platform at John Deere Dubuque Works and Director-Vehicles Marketing at John Deere Health Care, Inc. He received an undergraduate degree from the University of New Hampshire and an MBA from the University of Maine.
Floyd May is Chief Information Officer for SelectQuote, Inc. Mr. May received an undergraduate degree from Howard University School of Business.
Devon E.
May is currently serving as the Chief Financial Officer & Executive Vice President at American Airlines, Inc. and American Airlines Group, Inc. He previously held positions as the Managing Director-Financial Planning & Analysis at America West Airlines, Inc., and as the Vice President-Financial Planning & Analysis at US Airways Group, Inc. and US Airways, Inc. Mr. May completed his undergraduate degree at the University of Lethbridge and holds an MBA from Embry-Riddle Aeronautical University.
Jung Lung Hou is currently a Director at President International Development Corp.
Prior to his current position, he worked as a Non-Executive Director at Uni-President China Holdings Ltd.
from 2011 to 2017 and as a General Manager at Uni-President Enterprises Corp.
from 2016 to 2019.
He also held positions as Deputy General Manager & Head-Sales Department at Kirin Brewery (Zhuhai) Co. Ltd., Manager at Guangzhou President Enterprises Co., Ltd., General Manager & Head-Human Resources at Uni-President Enterprises (China) Investment Co., Ltd., and General Manager at Beijing President Enterprises Drinks & Food Co., Ltd.
Mr. Hou holds an MBA from Tsinghua University.
Cheng Lung Hu is on the board of Everest Textile Co., Ltd. and Far Eastern Apparel Co. Ltd. and General Manager-Textile at Far Eastern New Century Corp. Mr. Hu received an undergraduate degree from Tunghai University.
Fei Lung Kuo is on the board of Accton Technology (China) Co. Ltd. and Waveline Technologies Co., Ltd. and Chairman for Accton Technology Corp. He received an MBA from Saginaw Valley State University (Michigan).
Wei Lung Liau is Senior Deputy General Manager at AU Optronics Corp.
Fu Lung Hsieh occupies the position of General Manager for Wan Hai Lines Ltd. and Chairman of Wan Hai Lines Vietnam Ltd. (a subsidiary of Wan Hai Lines Ltd.). He is also on the board of 7 other companies. He received an undergraduate degree from National Taiwan Ocean University.
Chin Lung Hsiao is Senior Vice President-Operation Management at EVA Airways Corp.
Presently, Po Lung Ng occupies the position of Senior Manager-Administration at CK Asset Holdings Ltd.
Mr. Yau Lung Ho is a Chairman at Maple Peak Investments, Inc., a Chairman at Studio City International Holdings Ltd., a Chairman & Chief Executive Officer at Melco Resorts & Entertainment Ltd., a Chairman, Chief Executive Officer & MD at Melco International Development Ltd., a Chairman at Macau International Volunteers Association, a Honorary Patron at Canadian Chamber of Commerce In Macau, a Member at All-China Youth Federation, a Member of Macau Basic Law Promotion Association, a Member-Science & Technology Council of Special Administrative Region of Macau and a Vice Patron at The Community Chest of Hong Kong. He is on the Board of Directors at Melco Leisure & Entertainment Group Ltd., Better Joy Overseas Ltd., Lasting Legend Ltd., Quick Glitter Ltd., The Chinese General Chamber of Commerce, Macau Chamber of Commerce, The Canadian Chamber of Commerce in Hong Kong and The All-China Federation of Industry & Commerce. Mr. Ho was previously employed as a Chairman by Summit Ascent Holdings Ltd., a Chairman by Melco China Resorts (Holding) Ltd., a Chairman by The Chamber of Hong Kong Listed Cos., and a Chairman by Value Convergence Holdings Ltd. He received his undergraduate degree from the University of Toronto.
Kwok Lung Hongchoy is currently the Chief Executive Officer & Executive Director at Link Real Estate Investment Trust since 2010 and at Link Asset Management Ltd.
since 2009.
He is also a Director at Link Properties Ltd.
and a Trustee at the University of Pennsylvania.
Additionally, he serves as a Member-Supervisory Board at Tracker Fund of Hong Kong and as an Adjunct Professor at the University of Hong Kong since 2020.
Mr. Hongchoy is a Member of the Hong Kong Institute of Certified Public Accountants, the New Zealand Institute of Chartered Accountants, the Royal Institution of Chartered Surveyors, the Hong Kong Securities & Investment Institute, the Hong Kong Institute of Directors, the Institute of Shopping Centre Management, the Wharton School of the University of Pennsylvania's Asia Executive Board, and Chartered Accountants Australia & New Zealand.
Formerly, Mr. Hongchoy held positions as the Managing Director-Investment Banking at NM Rothschild & Sons (Hong Kong) Ltd., the Managing Director at DBS Asia Capital Ltd., and as a Director at Link Holdings Ltd.
He also served as a Director at the Asian Public Real Estate Association Ltd., Rishon Finance Ltd., Hong Kong Cyberport Management Co. Ltd., and the Hong Kong Applied Science & Technology Research Institute.
Additionally, he was a Professor at the Hong Kong Polytechnic University and a Trustee at the Urban Land Institute.
Mr. Hongchoy was also a Governor at the Forum Mondial de L'Economie.
In terms of education, Mr. Hongchoy completed his undergraduate studies at the University of Canterbury and holds an MBA from The Wharton School of the University of Pennsylvania.
Wen Lung Yen is a businessperson who has been at the head of 5 different companies and is Chairman of CTBC Financial Holding Co., Ltd. and Managing Director at United Real Estate Management Co. Ltd. Mr. Yen is also Chairman at Kainan University and on the board of 9 other companies. Mr. Yen previously occupied the position of Chairman of United Real Estate Management Corp. and Chairman for CTBC Life Insurance Co., Ltd. Mr. Yen received an undergraduate degree from Soochow University.
Lung Chun Wang currently works at Chang Hwa Commercial Bank Ltd., as Head-Information Technology Division from 2021.
Currently, Philippe Le May holds the position of Chief Technology Officer at Altice USA, Inc. In the past he held the position of Chief Technology Officer of Société Française de Radiotéléphone SA, Chief Technical Officer for Altice France SA and Head-Network at Lyonnaise Communications. Mr. Le May received an undergraduate degree from Télécom ParisTech.
May Ching Ng holds the position of Chief Information Officer at Maxis Bhd.
Presently, Ngan Yee Lung occupies the position of Finance Director & Executive Director at Swire Properties Ltd. Ms. Lung is also on the board of Brice Manufacturing Co., Inc. and Swire Properties MTN Financing Ltd. In her past career Ms. Lung was Executive Director at Hong Kong Aircraft Engineering Co., Ltd. and Finance Director of Swire Pacific Offshore Holding Ltd.
Madeline May Lung Cha has worked as a Director at Shibley Ltd.
since 2016.
May Lung Wong Cha is currently the Non-Executive Vice Chairman at HKR International Ltd.
She is also the Deputy Chairman & Executive Director at Mingly Corp., the Chairman at Sang Ma Trust Fund, the Director at LBJ Regents Ltd., Lucky Years Ltd., Chinney Holdings Ltd., Lucky Year Finance Ltd., Cha Textiles Ltd., and CCM Trust (Cayman) Ltd.
In her former positions, Ms. Wong Cha served as the Non-Executive Director at Hon Kwok Land Investment Co., Ltd.
from 1985 to 2014.
She was also a Non-Executive Director at Chinney Investments Ltd.
from 1987 to 2015.
Additionally, she held positions as a Director at CDW International Ltd.
and United Nigeria Textiles Plc.
May May Chan currently works at ZICOInsource, Inc., as Chief Executive Officer from 2015, DutaLand Bhd., as Independent Non-Executive Director from 2023, Pentamaster International Ltd., as Independent Non-Executive Director from 2017, and Malaysian Bar Association, as Member from 1991.
Ms. Chan also formerly worked at BGMC International Ltd., as Independent Non-Executive Director from 2017 to 2020, Dialog Group Bhd., as Head-Group Corporate Communications from 2012 to 2015, Zaid Ibrahim & Co., as Partner in 2005, and Media Chinese International Ltd., as General Manager-Project Operations from 2005 to 2012.
Ms. Chan received her graduate degree in 1990 from the University of Malaya.
May May Tan is currently a Director at Impact BPO Services Pte Ltd.
She previously worked as an Independent Non-Executive Director at Catalano Seafood Ltd.
Hee-Joong Cha is currently working as an Investor Relations Officer at SPG Co., Ltd.
Mr. Eric Cha, CFA MBA, is an Equity Research Analyst at Brown Advisory LLC.
He is responsible for covering the consumer discretionary and consumer staples sectors.
Prior to joining Brown Advisory in 2007, Mr. Cha worked as an equity analyst for Oppenheimer Funds and as an investment officer for Bethlehem Steel Pension Trust.
Prior to business school, he owned a retail business.
Mr. Cha received his undergraduate degree from the University of Virginia and an MBA from New York University.
He is a CFA charter holder.
Dong-Ha Cha is currently working as the CEO at NHN Investment Co., Ltd.
He previously worked as a Portfolio Manager at Samsung Venture Investment Corp.
Cha Patel is currently a Director at CityWest Homes Ltd.
Prior to this, they held Principal positions at The Toronto-Dominion Bank, Santander UK Plc, Grant Thornton UK LLP, and BMW (UK) Holdings Ltd.
Geun-Sig Cha is the founder and the Co-Chief Executive Officer & Director of i-SENS, Inc., a company founded in 2000.
He is currently the Director of i-Sens Hong Kong Ltd.
and I Sense Jiangsu Co., Ltd.
Additionally, Dr. Cha has been a Professor at Kwangwoon University since 1991.
He holds a doctorate degree from the University of Michigan and undergraduate and graduate degrees from Korea University.
Ki-Hwan Cha currently works at Barunson Co., Ltd., as Non-Executive Director.
Mr. Cha also formerly worked at Barunson Co., Ltd., as Independent Director and Pine Tree Investment & Management Co., Ltd., as Director & Auditor.
Mr. Cha received his graduate degree from Seoul National University.
David Cha is currently a Vice President at Hartford Investment Management Co. He completed his undergraduate degree at Middlebury College in 2010.
Jae-Yon Cha currently works at HANSSEM Co., Ltd., as Independent Director from 2021.
Ms. Cha also formerly worked at KT Corp., as Managing Director-Finance in 2014, BC Card Co., Ltd., as Executive Director & Head-Business Planning, and KT Telecop Co., Ltd., as Auditor from 1991 to 2014.
Ms. Cha received her graduate degree from Seoul National University.
Chang-Ik Cha currently works at CJ Systems Co., Ltd., as Head-Information Technology Consulting.
Eugene C.
Cha currently works at Hestia Insight, Inc., as Independent Director from 2022, Core Pacific Yamaichi Securities (HK) Ltd., as Non-Executive Director, and Chinese American Political Action Association, Inc., as Director.
Mr. Cha also formerly worked at STR Holdings, Inc., as Independent Director from 2014 to 2016 and Founder Fubon Fund Management Co., Ltd., as Independent Director.
Mr. Cha received his graduate degree in 1981 from the University of Michigan and graduate degree in 1978 from National Taiwan University.
Joseph H.
Cha is an Independent Director at IHS Nigeria Ltd.
since 2013.
He was previously an Independent Director at IHS Holding Ltd.
Mr. Cha holds an MBA from The Wharton School of the University of Pennsylvania.
Seong-Nam Cha is currently the Chief Executive Officer & Director at JW Life Science Corp.
He completed his undergraduate degree at Seoul National University.
Sarah Cha is a professional who has worked in the financial sector since 2014.
She is currently employed at Goldman Sachs & Co. LLC as a Financial Sector Specialist.
Prior to this, she worked as a Vice President at Deutsche Bank Securities, Inc. and as an Associate Analyst at UBS Securities LLC.
Ms. Cha received her undergraduate degree from the Massachusetts Institute of Technology in 2007.
Duk-Keun Cha formerly worked at Pan Ocean Co., Ltd., as Independent Director from 2005 to 2011.
Mr. Cha received his graduate degree from Seoul National University.
Sung-Min Cha currently works at Daelim B&Co Co., Ltd., as Director from 2023.
No results for this search
- Stock Market
- Advanced search
- May Lung Cha
